Quantcast

Palatin Technologies, Inc. To Report Fiscal Year 2010 Third Quarter Results; Teleconference and Webcast to be held on May 13, 2010

May 11, 2010

CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its third quarter, fiscal year 2010 financial results on Thursday, May 13, 2010 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 13, 2010, which will include discussion of the results of operations in greater detail and an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call / Webcast


     -Q3 & Fiscal Year 2010 Financial Results
                                Press Release      5/13/2010 at 7:30 a.m. ET

    - Q3 & Fiscal Year 2010 Conference Call-
     Live                                         5/13/2010 at 11:30 a.m. ET
    Domestic Dial-In Number                                   1-888-811-5436
    International Dial-In Number                              1-913-312-1386
    Pass code                                                        7740413

    - Q3 & Fiscal Year 2010 Conference Call-
     Replay                                                   5/13-5/20/2010
    Domestic Dial-In Number                                   1-888-203-1112
    International Dial-In Number                              1-719-457-0820
    Pass code                                                        7740413

    - Webcast Live and Replay Access                  http://www.palatin.com

The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin’s internally developed drug pipeline utilizes proprietary approaches to discover potent rigid conformers from flexible peptide starting points. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies’ website at www.palatin.com .

SOURCE Palatin Technologies, Inc.


Source: newswire



comments powered by Disqus